Intervacc AB Cash Flow Conversion Efficiency

Latest as of September 2025: -0.094x

Intervacc AB cash flow conversion efficiency. Based on the latest financial reports, Intervacc AB (IVACC) has a cash flow conversion efficiency ratio of -0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-29.33 Million ≈ $-3.16 Million USD) by net assets (Skr310.46 Million ≈ $33.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Intervacc AB (2015–2024)

Cash flow conversion efficiency of Intervacc AB from 2015 to 2024. This chart illustrates how Intervacc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IVACC stock price for real-time trading data and today's change.

Intervacc AB Cash Flow Conversion Ratio Explained

Intervacc AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Intervacc AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intervacc AB ranked by their cash flow conversion efficiency. Also see Intervacc AB (IVACC) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CALIX Ltd AU:CXL	-0.141x
Laser Photonics Corporation Common Stock NASDAQ:LASE	3.174x
Lulu's Fashion Lounge Holdings Inc NASDAQ:LVLU	-13.143x
Asia Brands Bhd KLSE:7722	0.015x
NATUZZI S.P.A. ADR/5 EO 1 F:NTZA	-0.043x
PGF Polska Grupa Fotowoltaiczna SA WAR:PGV	0.000x
Pyung Hwa Hldg KO:010770	0.224x
ANAX Metals Ltd AU:ANX	-0.076x

Annual Cash Flow Conversion Efficiency for Intervacc AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Intervacc AB from 2015 to 2024. Review IVACC cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr162.33 Million ≈ $17.47 Million	Skr-53.20 Million ≈ $-5.72 Million	-0.328x	-70.11%
2023-12-31	Skr237.93 Million ≈ $25.61 Million	Skr-45.83 Million ≈ $-4.93 Million	-0.193x	+30.95%
2022-12-31	Skr250.16 Million ≈ $26.92 Million	Skr-69.79 Million ≈ $-7.51 Million	-0.279x	-237.73%
2021-12-31	Skr308.25 Million ≈ $33.17 Million	Skr-25.46 Million ≈ $-2.74 Million	-0.083x	-38.88%
2020-12-31	Skr337.61 Million ≈ $36.33 Million	Skr-20.08 Million ≈ $-2.16 Million	-0.059x	-372.02%
2019-12-31	Skr219.82 Million ≈ $23.66 Million	Skr-2.77 Million ≈ $-298.10K	-0.013x	+40.50%
2018-12-31	Skr190.43 Million ≈ $20.49 Million	Skr-4.03 Million ≈ $-434.02K	-0.021x	+81.77%
2017-12-31	Skr164.90 Million ≈ $17.75 Million	Skr-19.16 Million ≈ $-2.06 Million	-0.116x	-260.12%
2016-12-31	Skr130.18 Million ≈ $14.01 Million	Skr-4.20 Million ≈ $-451.99K	-0.032x	+78.61%
2015-12-31	Skr126.52 Million ≈ $13.62 Million	Skr-19.09 Million ≈ $-2.05 Million	-0.151x	--

About Intervacc AB

ST:IVACC Sweden Biotechnology

Market Cap

$32.09 Million

Skr298.21 Million SEK

Market Cap Rank

#23324 Global

#439 in Sweden

Share Price

Skr0.88

Change (1 day)

+14.38%

52-Week Range

Skr0.61 - Skr1.39

All Time High

Skr89.40